Cohort profile update: the Swiss HIV cohort study (SHCS)
AU Scherrer, A Traytel, DL Braun… - International journal …, 2022 - academic.oup.com
The Swiss HIV Cohort Study (SHCS) provides a unique research platform for clinical,
translational, epidemiological, social and basic research. The SHCS was established in …
translational, epidemiological, social and basic research. The SHCS was established in …
Physical activity and exercise to improve cardiovascular health for adults living with HIV
C Ozemek, KM Erlandson, CM Jankowski - Progress in cardiovascular …, 2020 - Elsevier
Pharmacologic advancements in the treatment of human immunodeficiency virus (HIV) has
extended the life expectancy of people living with HIV (PLWH). An unfortunate side effect of …
extended the life expectancy of people living with HIV (PLWH). An unfortunate side effect of …
Exercise to prevent accelerated vascular aging in people living with HIV
Given advances in antiretroviral therapy, the mortality rate for HIV infection has dropped
considerably over recent decades. However, people living with HIV (PLWH) experience …
considerably over recent decades. However, people living with HIV (PLWH) experience …
Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible …
Importance Cardiovascular disease (CVD) is increased among people with HIV (PWH), but
little is known regarding the prevalence and extent of coronary artery disease (CAD) and …
little is known regarding the prevalence and extent of coronary artery disease (CAD) and …
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV
N Jaschinski, L Greenberg, B Neesgaard, JM Miró… - Aids, 2023 - journals.lww.com
Objective: Assessing whether the previously reported association between abacavir (ABC)
and cardiovascular disease (CVD) remained amongst contemporarily treated people with …
and cardiovascular disease (CVD) remained amongst contemporarily treated people with …
Coronary microcirculatory dysfunction in people with HIV and its association with antiretroviral therapy
DM Huck, B Weber, S Parks, S Divakaran… - Journal of the …, 2023 - Am Heart Assoc
Background HIV infection and abacavir‐containing antiretroviral regimens are associated
with vascular endothelial dysfunction and increased cardiovascular risk. Positron emission …
with vascular endothelial dysfunction and increased cardiovascular risk. Positron emission …
Cardiovascular challenges in the era of antiretroviral therapy for AIDS/HIV: A comprehensive review of research advancements, pathophysiological insights, and …
Cardiovascular disease, particularly coronary heart disease, is becoming more common
among those living with HIV. Individuals with HIV face an increased susceptibility to …
among those living with HIV. Individuals with HIV face an increased susceptibility to …
Coronary artery disease in persons with human immunodeficiency virus without detectable viral replication
AD Knudsen, A Fuchs, T Benfield… - Open forum …, 2023 - academic.oup.com
Background We aimed to determine the prevalence of coronary artery disease (CAD) in
persons with human immunodeficiency virus (HIV; PWH) and investigate whether …
persons with human immunodeficiency virus (HIV; PWH) and investigate whether …
[HTML][HTML] Multimorbidity and cardiovascular disease: a perspective on low-and middle-income countries
New and changing patterns of multimorbidity (MM), ie, multiple concurrent acute or chronic
diseases in a person, are emerging in low-and middle-income countries (LMICs). The …
diseases in a person, are emerging in low-and middle-income countries (LMICs). The …
Cardiovascular risks associated with protease inhibitors for the treatment of HIV
Introduction: Cumulative use of some first-generation protease inhibitors has been
associated with higher rates of dyslipidemia and increased risk of cardiovascular disease …
associated with higher rates of dyslipidemia and increased risk of cardiovascular disease …